Nishimura Naoko, Higuchi Yoshihisa, Kimura Nobusuke, Nozaki Fumihito, Kumada Tomohiro, Hoshino Ai, Saitoh Makiko, Mizuguchi Masashi
Division of Endocrinology and Metabolism, Aichi Children's Health and Medical Center, Aichi, Japan.
Department of Pediatrics, Otsu Red Cross Hospital, Shiga, Japan.
Pediatr Int. 2016 Nov;58(11):1215-1218. doi: 10.1111/ped.13119.
Most childhood cases of acute necrotizing encephalopathy (ANE) involve neither family history nor recurrence. ANE occasionally occurs, however, as a familial disorder or recurs in Caucasian patients. A mutation of RAN-binding protein 2 (RANBP2) has been discovered in more than one half of familial or recurrent ANE patients. In contrast, there has been no report of this mutation in East Asia. Here, we report the first sibling cases of typical ANE in Japan, with poor outcome. DNA analysis of genes associated with ANE or other encephalopathies, including RANBP2 and carnitine palmitoyl transferase II (CPT2), indicated neither mutations nor disease-related polymorphisms. On literature review, recurrent or familial ANE without the RANBP2 mutation has a more severe outcome and greater predilection for male sex than that with the RANBP2 mutation. This suggests that there are unknown gene mutations linked to ANE.
大多数儿童急性坏死性脑病(ANE)病例既无家族病史也无复发情况。然而,ANE偶尔会作为一种家族性疾病出现或在白种人患者中复发。在超过一半的家族性或复发性ANE患者中发现了RAN结合蛋白2(RANBP2)突变。相比之下,东亚地区尚未有关于这种突变的报道。在此,我们报告了日本首例典型ANE的同胞病例,预后较差。对与ANE或其他脑病相关的基因进行DNA分析,包括RANBP2和肉碱棕榈酰转移酶II(CPT2),结果显示既无突变也无疾病相关的多态性。经文献回顾,无RANBP2突变的复发性或家族性ANE比有RANBP2突变的ANE预后更差,且更易发生于男性。这表明存在与ANE相关的未知基因突变。